Syncytial giant cell hepatitis (GCH) is a condition characterized by inflammation and multinucleated hepatocytes, commonly found in wide spectrum of neonatal and infantile liver diseases [1].
Westerhoff et al., "Neonatal giant cell hepatitis: Histological and etiological findings," The American Journal of Surgical Pathology, vol.
Giant cell hepatitis with autoimmune hemolytic anemia in children: Proposal for therapeutic approach.
[sup][3] Liver biopsy often shows
giant cell hepatitis, and at late stages, bridging fibrosis and micronodular cirrhosis can also be seen.
A wide spectrum of primary liver diseases in systemic lupus erythematosus have been demonstrated by various authors and include viral hepatitis, autoimmune hepatitis, primary biliary cirrhosis, granulomatous hepatitis, giant cell hepatitis, chronic hepatitis with IgA or IgD deficiency, porphyria or idiopathic portal hypertension, and rarely lymphoma.
McMahon, "Giant cell hepatitis associated with systemic lupus erythematosus," Journal of Clinical Pathology, vol.
Giant cell hepatitis associated with direct Coombs' test-positive hemolytic anemia is a rare condition of childhood and the pathogenesis remains unclear.
Key words: Giant cell hepatitis, immune hemolytic anemia, direct Coombs' test, rituximab
Liver histology showed, among other features, a
giant cell hepatitis which has not yet been described for drug-induced liver disease (Zimmerman, 1999).
Then doctors discovered Rachel had
giant cell hepatitis, a rare but still treatable type of hepatitis.
This leaves a large group of infants with what is called IDIOPATHIC NEONATAL HEPATITIS,
Giant Cell Hepatitis or familial Cholestatis.
Giant cell hepatitis, however, is usually caused by various degrees of insults to the immature liver, or can be idiopathic.